5 research outputs found
Recommended from our members
Effects of Distal Mutations on the Structure, Dynamics and Catalysis of Human Monoacylglycerol Lipase
An understanding of how conformational dynamics modulates function and catalysis of human monoacylglycerol lipase (hMGL), an important pharmaceutical target, can facilitate the development of novel ligands with potential therapeutic value. Here, we report the discovery and characterization of an allosteric, regulatory hMGL site comprised of residues Trp-289 and Leu-232 that reside over 18 Ã… away from the catalytic triad. These residues were identified as critical mediators of long-range communication and as important contributors to the integrity of the hMGL structure. Nonconservative replacements of Trp-289 or Leu-232 triggered concerted motions of structurally distinct regions with a significant conformational shift toward inactive states and dramatic loss in catalytic efficiency of the enzyme. Using a multimethod approach, we show that the dynamically relevant Trp-289 and Leu-232 residues serve as communication hubs within an allosteric protein network that controls signal propagation to the active site, and thus, regulates active-inactive interconversion of hMGL. Our findings provide new insights into the mechanism of allosteric regulation of lipase activity, in general, and may provide alternative drug design possibilities
Recommended from our members
Probing the Carboxyester Side Chain in Controlled Deactivation (−)-Δ8-Tetrahydrocannabinols
We recently reported on a controlled deactivation/detoxification approach for obtaining cannabinoids with improved druggability. Our design incorporates a metabolically labile ester group at strategic positions within the THC structure. We have now synthesized a series of (−)-Δ8-THC analogues encompassing a carboxyester group within the 3-alkyl chain in an effort to explore this novel cannabinergic chemotype for CB receptor binding affinity, in vitro and in vivo potency and efficacy, as well as controlled deactivation by plasma esterases. We have also probed the chain’s polar characteristics with regard to fast onset and short duration of action. Our lead molecule, namely 2-[(6aR,10aR)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-3-yl]-2-methyl-propanoic acid 3-cyano-propyl ester (AM7438), showed picomolar affinity for CB receptors and is deactivated by plasma esterases while the respective acid metabolite is inactive. In further in vitro and in vivo experiments, the compound was found to be a remarkably potent and efficacious CB1 receptor agonist with relatively fast onset/offset of action
Probing the Carboxyester Side Chain in Controlled Deactivation (−)‑Δ<sup>8</sup>‑Tetrahydrocannabinols
We
recently reported on a controlled deactivation/detoxification approach
for obtaining cannabinoids with improved druggability. Our design
incorporates a metabolically labile ester group at strategic positions
within the THC structure. We have now synthesized a series of (−)-Δ<sup>8</sup>-THC analogues encompassing a carboxyester group within the
3-alkyl chain in an effort to explore this novel cannabinergic chemotype
for CB receptor binding affinity, in vitro and in vivo potency and
efficacy, as well as controlled deactivation by plasma esterases.
We have also probed the chain’s polar characteristics with
regard to fast onset and short duration of action. Our lead molecule,
namely 2-[(6a<i>R</i>,10a<i>R</i>)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-6<i>H</i>-dibenzoÂ[<i>b</i>,<i>d</i>]Âpyran-3-yl]-2-methyl-propanoic
acid 3-cyano-propyl ester (AM7438), showed picomolar affinity for
CB receptors and is deactivated by plasma esterases while the respective
acid metabolite is inactive. In further in vitro and in vivo experiments,
the compound was found to be a remarkably potent and efficacious CB1
receptor agonist with relatively fast onset/offset of action